Clinical Research Directory

Inclusion Criteria: * Subjects aged between 25 and 75 years at the time of signing the informed consent form. * Subjects undergoing unilateral breast surgery. * Subjects in good physical and psychological health. * Subjects who have voluntarily provided written informed consent, either personally or, where applicable, through a family member, custodian, or legal representative. * Subjects willing to comply with the study procedures, including the instructions for use of the assigned product and attendance at the scheduled follow-up visits. Exclusion Criteria: * Pregnant or breastfeeding women. * Subjects with a history of chronic or currently active skin disease that, in the investigator's opinion, may adversely affect dermal regeneration. * Subjects with diseases or disorders that, in the investigator's opinion, could interfere with the assessment of safety or effectiveness. * Subjects with any acute infectious disease. * Subjects with any systemic disease that could worsen the prognosis in the event of an adverse event, including poorly controlled diabetes with retinopathy or peripheral vascular disease, severe hypertension, or other serious disease. * Subjects who are members of the study team, including investigators, collaborators, nursing staff, site employees, or any other person directly involved in the conduct of the protocol. * Subjects with a skin phototype greater than V